After fight with husband, woman files case: NIA steps in to probe ‘forced conversion’

Kochi, Jul 15: Alisha P Shaji, a commerce student from Kerala's Kochi scored 499 out of 500 in the Central Board of Secondary Education (CBSE) class 12 results declared on Monday, wants to pursue a career in economics.

While talking to news agency on Tuesday, she said that she never joined coaching classes.

"I was surprised after knowing the unexpected result. I never expected this, I expected close to 98 per cent. I had five subjects to write but I could attempt only three as two were postponed. I am sad that I could not attempt them, but I am happy that I scored 100 in those subjects. In future, I want to pursue a degree in economics," she said.

"My friends, family and teachers are very supportive and I am thankful to them. I never went to tuitions. I used to study four to five hours a day," she added.

Alisha further said that she wants to give the message that it is okay to start late, but continuity is key to achieve good results.
CBSE on Monday had declared the results for Class 12 examinations 2020.

As per CBSE, with 88.78 per cent pass percentage this year for Class 12, the pass percentage has increased by 5.38 per cent. Last year, the pass percentage was 83.40 per cent. 

Bengaluru, May 17: Karnataka on Sunday extended lockdown for two days until midnight of Tuesday, May 19. Earlier today, Tamil Nadu and Maharashtra extended the lockdown till May 31. The state government said that the guidelines and norms as followed during Coronavirus Lockdown 3 will remain in place till 19th midnight or till further notice.

Meanwhile, the total number of coronavirus cases in Karnataka rose to 1,146 on Saturday. With 37 deaths and 497 discharges, there are 611 active corona cases in the state. 

Out of 54 new cases, twentytwo are from Mandya, ten from Kalaburagi, six from Hassan, four from Dharwad, three each from Yadgir and Kolar, two each from Dakshina Kannada and Shivamogga, and one each from Udupi and Vijayapura.

French Nobel prize winning scientist Luc Montagnier has sparked a fresh controversy by claiming that the SARS-CoV-2 virus came from a lab, and is the result of an attempt to manufacture a vaccine against the AIDS virus.

In an interview given to French CNews channel and during a podcast by Pourquoi Docteur, professor Montagnier who co-discovered HIV (Human Immunodeficiency Virus) claimed the presence of elements of HIV in the genome of the coronavirus and even elements of the "germ of malaria" are highly suspect, according to a report in Asia Times.

"The Wuhan city laboratory has specialized in these coronaviruses since the early 2000s. They have expertise in this area," he was quoted as saying.

The theory that Covid-19 virus originated in the lab is making rounds for quite some time.

US President Donald Trump last week acknowledged Fox News report that the novel coronavirus may have been accidentally leaked by an intern working at the Wuhan Institute of Virology in China.

The Fox News, in an exclusive report, based on unnamed sources has claimed that though the virus is a naturally occurring strain among bats and not a bioweapon, but it was being studied in Wuhan laboratory.

The initial transmission of the virus was bat-to-human, the news channel said, adding that the "patient zero" worked at the laboratory. The lab employee was accidentally infected before spreading the disease among the common people outside the lab in Wuhan city.

Professor Montagnier was awarded the 2008 Nobel Prize in Medicine for the identification of AIDS virus, with his colleague professor Franeoise Barre-Sinoussi.

His fresh claim on coronavirus, however, received criticism from scientists, including his colleagues.

"Just in case you don't know. Dr Montagnier has been rolling downhill incredibly fast in the last few years. From baselessly defending homeopathy to becoming an antivaxxer. Whatever he says, just don't believe him," tweeted Juan Carlos Gabaldon.

As per a recent Washington Post, two years ago, the US embassy officials in China raised concerns about the insufficient biosafety at the Chinese government's Wuhan Institute of Virology where deadly viruses and infectious diseases are studied.

Though the institute, located quite close to the Wuhan wet market, is China's first biosafety level IV lab, the US state department had warned in 2018 about "serious shortage of appropriately trained technicians and investigators needed to safely operate this high-containment laboratory".